These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15968810)

  • 1. Ask us: Some drugs affect tooth movement.
    Schwartz JE
    Am J Orthod Dentofacial Orthop; 2005 Jun; 127(6):644. PubMed ID: 15968810
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone.
    Ottewell PD; Woodward JK; Lefley DV; Evans CA; Coleman RE; Holen I
    Mol Cancer Ther; 2009 Oct; 8(10):2821-32. PubMed ID: 19789217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of bisphosphonates in cancer.
    Coleman RE; Purohit OP; Vinholes JJ
    Acta Oncol; 1996; 35 Suppl 5():23-9. PubMed ID: 9142961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Zoledronic acid and bone pathology in the course of neoplasia. Part I].
    Caffo O
    Tumori; 2005; 91(5):22-6. PubMed ID: 16459649
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ibandronate: keep life in motion].
    Longo F; Mansueto G
    Tumori; 2004; 90(2):9-16. PubMed ID: 15237599
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bisphosphonates in the treatment of breast carcinoma].
    Stajszczyk M; Mykała-Cieśla J
    Pol Arch Med Wewn; 2001 Aug; 106(2):729-38. PubMed ID: 11926150
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel approaches to the management of bone metastases in patients with breast cancer.
    Hortobagyi GN
    Semin Oncol; 2002 Jun; 29(3 Suppl 11):134-44. PubMed ID: 12138408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments of aminobisphosphonates: the double face of Janus.
    Santini D; Galluzzo S; Vincenzi B; Schiavon G; Fratto E; Pantano F; Tonini G
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi164-7. PubMed ID: 17591815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronic acid prevents cancer treatment-induced bone loss.
    Oncology (Williston Park); 2005 Mar; 19(3):390. PubMed ID: 15828553
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preclinical and clinical profile of zoledronic acid (Zometa) for hypercalcemia of malignancy].
    Tomoo T; Suzuki M
    Nihon Yakurigaku Zasshi; 2005 Nov; 126(5):353-7. PubMed ID: 16394581
    [No Abstract]   [Full Text] [Related]  

  • 11. Zoledronic acid: past, present and future roles in cancer treatment.
    Saad F
    Future Oncol; 2005 Apr; 1(2):149-59. PubMed ID: 16555985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bisphosphonates and bone metastases of solid tumors: therapeutic interest despite its anti-resorptive properties].
    Clézardin P
    Prog Urol; 2003 Apr; 13(2 Suppl 1):28-35. PubMed ID: 12815807
    [No Abstract]   [Full Text] [Related]  

  • 13. Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatment.
    Criscitiello C; Viale G; Gelao L; Esposito A; De Laurentiis M; De Placido S; Santangelo M; Goldhirsch A; Curigliano G
    Cancer Treat Rev; 2015 Feb; 41(2):61-8. PubMed ID: 25499997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing cancer-related skeletal events with bisphosphonates.
    Rule S
    Hosp Med; 2004 Jun; 65(6):355-60. PubMed ID: 15222212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone.
    Balke M; Campanacci L; Gebert C; Picci P; Gibbons M; Taylor R; Hogendoorn P; Kroep J; Wass J; Athanasou N
    BMC Cancer; 2010 Aug; 10():462. PubMed ID: 20799989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoledronic acid: a new advance in managing skeletal events in prostate cancer.
    Kirby RS
    BJU Int; 2003 Apr; 91(6):464-5. PubMed ID: 12656892
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of zoledronic acid in the treatment of breast cancer].
    Chen J; Liu ZY; Zhao LJ
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):318-9. PubMed ID: 21575510
    [No Abstract]   [Full Text] [Related]  

  • 18. Cisplatin as an active treatment in zoledronate-refractory hypercalcemia.
    Lin PH; Chiu CF; Lu YS
    Ann Oncol; 2011 May; 22(5):1244-1246. PubMed ID: 21460375
    [No Abstract]   [Full Text] [Related]  

  • 19. Preclinical pharmacology of zoledronic acid.
    Green JR
    Semin Oncol; 2002 Dec; 29(6 Suppl 21):3-11. PubMed ID: 12584689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates for metastatic bone pain.
    Body JJ
    Support Care Cancer; 1999 Jan; 7(1):1-3. PubMed ID: 9926966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.